Literature DB >> 14571029

The significance of corpora amylacea in mesial temporal lobe epilepsy.

P Joseph Cherian1, V V Radhakrishnan, K Radhakrishnan.   

Abstract

Temporal lobe epilepsy (TLE) associated with mesial temporal sclerosis (MTS), mesial TLE (MTLE), is the commonest medically refractory adult epilepsy syndrome. Corpora amylacea (CoA) have been shown to be a marker of MTS. We compared 9 patients with MTS who had dense deposition of CoA in their hippocampi with 25 patients with MTS who did not have CoA. The patients with CoA were significantly older and they showed a trend towards having a significantly longer duration of epilepsy. The postoperative seizure outcome at 2 years was not different in the 2 groups. Our results could indicate the progressive nature of the pathology of MTS, probably indicating excitotoxic damage due to recurrent seizures, but they need to be verified by clinicopathological correlation among a larger number of patients with MTLE.

Entities:  

Mesh:

Year:  2003        PMID: 14571029

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  4 in total

Review 1.  Does abnormal glycogen structure contribute to increased susceptibility to seizures in epilepsy?

Authors:  Mauro DiNuzzo; Silvia Mangia; Bruno Maraviglia; Federico Giove
Journal:  Metab Brain Dis       Date:  2014-03-19       Impact factor: 3.584

2.  Corpora amylacea mimicking low-grade glioma and manifesting as a seizure: Case report.

Authors:  Seung J Lee; Minsu Kim; Carlito Lagman; Timothy T Bui; William H Yong; Isaac Yang
Journal:  Surg Neurol Int       Date:  2017-04-26

3.  Quantitative analysis of size and regional distribution of corpora amylacea in the hippocampal formation of obstructive sleep apnoea patients.

Authors:  Cuicui Xu; Jessica E Owen; Thorarinn Gislason; Bryndis Benediktsdottir; Stephen R Robinson
Journal:  Sci Rep       Date:  2021-10-22       Impact factor: 4.379

4.  Corpora Amylacea in Neurodegenerative Diseases: Cause or Effect?

Authors:  Troy T Rohn
Journal:  Int J Neurol Neurother       Date:  2015-08-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.